Events9th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2023-15687 (registering DOI)
This submission belongs to the session S4. New Small molecules as drug candidates of the event 9th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2023
Academic Editor
author-avatarAlfredo Berzal-Herranz
Citation
Sergiy Vlasov, Hanna Severina, Olena Vlasova, Oleksandr V. Borysov, Pavlo E. Shynkarenko, Victoriya Georgiyants, The comparative study of antimicrobial activity for 4-methylthieno[2,3-d]pyrimidine and their 4-oxo analogues, in Proceedings of 9th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2023, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2023-15687
Share
Email
Facebook
Twitter
LinkedIn

The comparative study of antimicrobial activity for 4-methylthieno[2,3-d]pyrimidine and their 4-oxo analogues

image
Olena Vlasova 1
Oleksandr V. Borysov 2,3
Pavlo E. Shynkarenko 4
1. Department of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska str., 61002 Kharkiv, Ukraine, Ukraine
2. Institute of Organic Chemistry of the NASU, 5 Academician Kukhar str., 02660 Kyiv, Ukraine, Ukraine
3. Enamine Ltd., 78 Chervonotkatska str., 02094 Kyiv, Ukraine
4. Enamine Ltd., 78 Chervonotkatska str., 02094 Kyiv, Ukraine, Ukraine
Abstract

The most effective small molecular inhibitors of TrmD with confirmed in vivo antibacterial activity contain either 3-indolyl of thieno[2,3-d]pyrimidine moiety. Recently we have reported the antimicrobial activity of the synthetically available 4-methylthieno[2,3-d]pyrimidine-6-carboxamides with benzyl substituents at the primary amide fragment as effective antimicrobials with the predicted affinity to TrmD isolated from P. aeruginosa. It was also reported that 4-oxothieno[2,3-d]pyrimidine derivatives were more effective TrmD inhibitors rather than their 4-alkoxy analogues with aromatic pyrimidine fragment. Therefore we have prepared N-(benzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamides as the close analogues, which turned out to be active in vitro against the strains of S. aureus and B. subtilis and only moderately active against P. aeruginosa strain. Docking studies showed that despite the good values of the scoring functions, the conformational analysis of the ligands’ poses in the active site revealed their ability for only partial inhibition of TrmD of P. aeruginosa. The study revealed better activity for N-benzyl-4,5-dimethylthieno[2,3-d]pyrimidine-6-carboxamide against P. aeruginosa in comparison to their 4-oxo analogues.

Keywords
thiophene
pyrimidine
TrmD
antibacterials
Manuscript
Oral Presentation
Poster
corrected_9th-ECMC_Poster_template_Vlasov_2.pdf
Novel semi-synthetic antibacterial agents against Staphylococcus aureus and Bacillus cereus
Lipophilic Ru(III)-based complexes as potential anticancer drug candidates